Professional Medical Education Grants support US healthcare professionals through independent medical education, research fellowships, and awards funded by Novartis to improve patient care.
Funder: Novartis
Due Dates: October 1, 2026 (NGCS submission cutoff) | November 16, 2026 (scheduled platform launch) | At least 60 calendar days before activity start (complete application)
Funding Amounts: Funding availability differs by disease area; fellowship terms up to 1 year, with additional-year applications permitted
Summary: Supports independent, non-promotional medical education for US healthcare professionals to improve patient care, plus eligible research fellowships and awards.
Key Information: Requests must be disease-focused and within Novartis’s identified therapeutic areas of interest.
Novartis supports high-quality professional medical education for US healthcare professionals through independently requested educational grants. Supported formats include live events, web-based education, and enduring materials, whether accredited or non-accredited. Programs must be independent of commercial bias and non-promotional. Novartis also considers research fellowships and awards, including established nonprofit fellowship programs addressing identified education gaps in its therapeutic areas.
Educational priorities include disease mechanisms, screening and diagnosis, current and emerging treatment evidence, and clinical guidelines. Across its oncology and non-oncology interests, Novartis emphasizes individualized treatment, multidisciplinary care, disease and treatment-response monitoring, patient-reported outcomes, and quality of life. Timely referrals, shared decision-making, adherence, and barriers to optimal care are also priorities.